NUWELLIS NUWE 深 沪
等待开盘 04-03 09:30:00 美东时间
1.09
0.000
0.00%
华盛通- 最 高1.10
- 今 开1.09
- 成交量 2.50万股
- 最 低 1.04
- 昨 收 1.09
- 总市值 251.84万
- 52周最高 45.4188
- 市盈率 静 --
- 换手率 1.08%
- 52周最低 0.96
- 委 比 53.67%
- 总股本 231.05万
- 历史最高 2012724000.00
- 量 比 0.33
- 振 幅 5.50%
- 历史最低 0.96
- 每 手 1
- 风险率 13.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nuwellis Reports ~50% Of U.S. Revenue In 2025
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces continued momentum in its pediatric category, which is now the Company's
03-31 20:33
美股夜盘 | STRATS Trust for Allstate Corp For Dominion Res Strt Ctf 05-6涨226.26%，PMGC Holdings Inc.涨89.22%
System1 Inc涨-21.08%；GlucoTrack Inc涨-15.92%；NUWELLIS涨-13.33%
03-30 08:10
BRIEF-Nuwellis Completes Acquisition Of Rendiatech
BRIEF-Nuwellis Completes Acquisition Of Rendiatech March 17 (Reuters) - Nuwellis Inc NUWE.O : NUWELLIS COMPLETES ACQUISITION OF RENDIATECH Source text: ID:nGNXkkw0L Further company coverage: NUWE.O (( Reuters.Briefs@thomsonreuters.com ;))
03-17 20:03
Nuwellis Q4 EPS $(1.50) Beats $(1.56) Estimate, Sales $2.424M Beat $2.310M Estimate
Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.56) by 3.85 percent. This is a 91.8 percent increase over losses of $(18.30) per share from the same
03-10 20:16
Earnings Scheduled For March 10, 2026
Companies Reporting Before The Bell • Ultralife (NASDAQ:ULBI) is likely to repo...
03-10 19:11
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Zevra Therapeutics (NASDAQ:ZVRA) stock moved upwards by 20.6% to $11.0...
03-10 05:05
Nuwellis Earnings Preview
Nuwellis (NASDAQ:NUWE) is gearing up to announce its quarterly earnings on Tues...
03-10 00:02
BRIEF-Nuwellis Appoints Dr. Stuart L. Goldstein As Director Of Clinical Strategy To Advance Pediatric And Cardiorenal Strategy
BRIEF-Nuwellis Appoints Dr. Stuart L. Goldstein As Director Of Clinical Strategy To Advance Pediatric And Cardiorenal Strategy March 5 (Reuters) - Nuwellis Inc NUWE.O : NUWELLIS APPOINTS DR. STUART L. GOLDSTEIN AS DIRECTOR OF CLINICAL STRATEGY TO ADVANCE PEDIATRIC AND CARDIORENAL STRATEGY Source tex
03-05 21:05
Nuwellis Appoints Carisa Schultz CFO, Effective Feb. 2
Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026.Ms.
01-30 21:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) shares rose 81.5% to $3.9 during Tuesday's regu...
01-28 01:05
